Back to Journals » Clinical Ophthalmology » Volume 13

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Total article views   HTML views PDF downloads Totals
4,897 Dovepress* 4,718+ 1,441 6,159
PubMed Central* 179 60 239
Totals 4,897 1,501 6,398
*Since 24 January 2019

View citations on PubMed Central and Google Scholar